METHODS FOR TREATING IL-6 MEDIATED INFLAMMATION WITHOUT IMMUNOSUPPRESSION

Neutralizing antibodies to circumsporozoite protein and their use

APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF

BINDING MOLECULES

INHIBITOR OF SURFACE PROTEIN (SP-D) / SIRPA / SHP2 PATHWAY FOR USE IN THE PREVENTION AND/OR TREATMENT OF SECONDARY INFECTION

HUMANIZED ANTIBODY

Multispecific Anti-HIV Antibodies

COMPOSITIONS AND METHODS RELATED TO ANTIBODIES THAT NEUTRALIZE COAGULASE ACTIVITY DURING STAPHYLOCOCCUS AUREUS DISEASE

METHODS AND COMPOSITIONS FOR DETERMINING THE BIODISTRIBUTION OF ACTIVATABLE ANTI-CD166 ANTIBODY CONJUGATES

Anti-EGFR antibody-drug conjugates

ANTHRACYCLINE ANTIBODY-DRUG CONJUGATES AND USES THEREOF

Substituted pyrimidines as vaccine adjuvants

COMBINATION THERAPY FOR TREATING CANCER

METHOD TO INDUCE HEMATOPOIETIC CHIMERISM

Gene-regulating compositions and methods for improved immunotherapy

T cell activating bispecific antigen binding molecules

Treatment of allergic diseases with chimeric protein

Antibodies and antigen binding peptides for factor XIa inhibitors and uses thereof

ANTI-CD73 ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF AND APPLICATION THEREOF

Humanized BCMA antibody and BCMA-CAR-T cells

BISPECIFIC ANTIBODY BINDING TO CD40 AND GPC3

APJ MODULATORS AND USES THEREOF

METHOD OF TREATING NEUTROPHILIC CONDITIONS

TREATING CHRONIC LIVER DISEASE

Anti-GPRC5D monoclonal antibodies and uses thereof

COMBINATION THERAPY FOR TREATMENT AND PREVENTION OF AUTOIMMUNE AND INFLAMMATORY DISEASES

ANTIBODY TO HUMAN IL-1 BETA

ANTI-ALPHA-SYNUCLEIN ANTIBODIES

CHIMERIC RECEPTOR THERAPY

Separation moieties and methods of use thereof

ENDOSIALIN-BINDING ANTIBODY

Human antibodies to PCSK9 for use in methods of treating particular groups of subjects

IMMUNE CHECKPOINT INHIBITOR COMBINATION THERAPY USING QUINOLINE CARBOXAMIDE DERIVATIVE

Combinational uses of nitroxoline and its analogues with chemotherapies and immunotherapies in the treatment of cancers

Combinational uses of nitroxoline and its analogues with chemotherapies and immunotherapies in the treatment of cancers

Method of treating aging-associated cognitive impairment by reducing CCR3

Factor VII (FVII(a))/TREM-like transcript 1 (TLT-1) bispecific antibodies

Polypeptides comprising immunoglobulin single variable domains targeting glypican-3 and T cell receptor

Anti-human ephrin B1 antibodies and uses thereof

Bispecific polypeptides against CD137

COMBINATION THERAPY OF MULTIPLE SCLEROSIS COMPRISING A CD20 LIGAND

ANTI-BCMA ANTIBODIES

Immunomodulatory antibodies

MÜLLERIAN INHIBITING SUBSTANCE TYPE 2 RECEPTOR (MISIIR)-SPECIFIC CAR T CELLS FOR THE TREATMENT OF OVARIAN CANCER AND OTHER GYNECOLOGIC MALIGNANCIES

Dosing Regimens of Bispecific CD123 x CD3 Diabodies in the Treatment of Hematologic Malignancies

Multifunctional natural killer (NK) cell engagers binding to NKp46 and CD123

ANTI-TIE2 ANTIBODY AND USE THEREOF

BIFUNCTIONAL FUSION PROTEIN AGAINST PDL1 AND TGFß AND USE THEREOF

BISPECIFIC ANTIBODIES AGAINST CHI3L1 AND PD1 WITH ENHANCED T CELL-MEDIATED CYTOTOXIC EFFECTS ON TUMOR CELLS

BISPECIFIC ANTIBODIES AGAINST PD-1 AND LAG-3

Anti-CEACAM6 antibodies and methods of use

Methods of treating neurodegenerative diseases

COMPOSITIONS AND METHODS RELATED TO XCT ANTIBODIES

Anti-BAG3 antibodies as therapeutic reagent in cardiovascular disease

ANGIOPOIETIN-LIKE 4 ANTIBODIES AND METHODS OF USE

Prophylactic and/or therapeutic agent of infectious diseases or inflammatory diseases

ANTIBODIES AGAINST SARS-COV-2 SPIKE PROTEIN

COMBINATION RADIOIMMUNOTHERAPY AND CD47 BLOCKADE IN THE TREATMENT OF CANCER

COMPOSITIONS AND METHODS OF IMMUNODEPLETION FOR THE TREATMENT OF MALIGNANT AND NON-MALIGNANT HEMATOLOGICAL DISEASES

Modulating gabarap to modulate immunogenic cell death

ABT-165 IN COMBINATION WITH FOLINIC ACID, 5-FLUOROURACIL, AND IRINOTECAN FOR THE TREATMENT OF CANCERS

THERAPY GUIDANCE AND/OR THERAPY MONITORING FOR A TREATMENT WITH ANGIOTENSIN-RECEPTOR-AGONIST AND/OR A PRECURSOR THEREOF

USE OF MVA OR MVADELTAE3L AS IMMUNOTHERAPEUTIC AGENTS AGAINST SOLID TUMORS

GENOMIC SAFE HARBORS FOR TRANSGENE INTEGRATION

Formulations of 2-(4-chlorophenyl)-N-((2-(2,6- dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

DRY MICROPARTICLES

METHODS FOR DETERMINING DIFFERENCES IN ALPHA-4 INTEGRIN ACTIVITY BY CORRELATING DIFFERENCES IN sVCAM AND/OR sMAdCAM LEVELS

METHODS AND SYSTEMS FOR DETECTING CORONAVIRUS

Anti-physaliatoxin single-domain antibody COZO32, preparation method, and use thereof

Anti-complement C1s antibodies and uses thereof

Antibodies that recognize red blood cell antigens

ANTIBODIES AGAINST THE ECTODOMAIN OF ERBB3 AND USES THEREOF

ANTI-CD20 COMBINATIONS FOR TREATING TUMORS

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR

ANTI-CD137 MOLECULES AND USE THEREOF

SILENT Fc VARIANTS OF ANTI-CD40 ANTIBODIES

FC-MODIFIED BIOLOGICALS FOR LOCAL DELIVERY TO COMPARTMENTS, IN PARTICULAR TO THE CNS

ANTI-TRKA ANTIBODIES AND USES THEREOF

COMPOSITIONS AND METHODS FOR TARGETED IMMUNOMODULATORY ANTIBODIES AND FUSION PROTEINS

Efflux Pump-Cancer Antigen Multi-Specific Antibodies and Compositions, Reagents, Kits and Methods Related Thereto

Bispecific and monospecific antibodies using novel anti-PD-1 sequences

ANTIBODIES AGAINST PROGRAMMED CELL DEATH PROTEIN 1 (PD1) AND USES THEREOF

Methods of treating HLA-E-expressing cancers by administering antibodies which bind human natural killer cell inhibitory receptor group 2A (NKG2A)

USE OF AN ANTI-CD19 ANTIBODY TO TREAT AUTOIMMUNE DISEASE

Humanized antibody specific for CD22 and chimeric antigen receptor using the same

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

Antibody or chimeric antigen receptor which targets Claudin 18.2

ANTI-ANG2 ANTIBODY AND USE THEREOF

ANTI-TAU ANTIBODY AND USE OF SAME

NOVEL CTHRC1-SPECIFIC ANTIBODY AND USE THEREOF

Compositions and methods comprising SFRP2 antagonists

Antibody molecules and uses thereof

Compositions and methods for the removal of biofilms

Ha binding agents

ANTI-SARS-COV-2 ANTIBODIES AND USES THEREOF

Antibody-based blockage of SARS-CoV-2-specific furin cleavage site

VARIABLE LYMPHOCYTE RECEPTORS THAT TARGET THE BLOOD BRAIN BARRIER AND METHODS OF USE

IMMUNOSTIMULATORY LIPOPLEX, PHARMACEUTICAL COMPOSITION INCLUDING IMMUNOSTIMULATORY LIPOPLEX, AND USES THEREOF

CEACAM5 ANTIBODY-DRUG CONJUGATE FORMULATION

COMBINED PHARMACEUTICAL COMPOSITION

Methods of treatment of temozolomide-resistant glioma using coenzyme Q10

FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTIBODY THERAPEUTICS

COMBINATORIAL CAR T CELL AND HEMATOPOEITIC STEM CELL GENETIC ENGINEERING FOR SPECIFIC IMMUNOTHERAPY OF MYELOID LEUKEMIAS

PCSK9 INHIBITORS FOR NEUROPATHY

Heavy chain antibodies binding to PSMA

Bispecific antibodies against CEACAM5 and CD47

ANTI-CEA IMMUNOCONJUGATES, AND USES THEREOF

ANTI-CD40 ANTIBODIES FOR USE IN TREATMENT OF TIDM AND INSULITIS

MANUFACTURING ANTI-BCMA CAR T CELLS

Rank Pathway Inhibitors in Combination with CDK Inhibitors

IMMUNOGLOBULIN PROTEINS THAT BIND TO NPR1 AGONISTS

Anti-CCR8 monoclonal antibodies and uses thereof

METHOD OF TREATING KELOIDS

Anti-axl antagonistic antibodies

MODULATION OF WNT SIGNALING IN GASTROINTESTINAL DISORDERS

Fc-MODIFIED BIOLOGICALS FOR LOCAL DELIVERY TO COMPARTMENT, IN PARTICULAR TO THE CNS

Clinical methods for use of a PD-L1-binding molecule comprising a Shiga toxin effector

ANTIBODIES AGAINST PROGRAMMED DEATH-LIGAND 1 AND USES THEREOF

Antibodies binding human and monkey CD3 and uses thereof

Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A)

PRECURSOR TRI-SPECIFIC ANTIBODY CONSTRUCTS AND METHODS OF USE THEREOF

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

COMPOSITIONS AND METHODS FOR INHIBITING CANCER STEM CELLS

MONOCLONAL ANTIBODIES TO PROGASTRIN AND THEIR USES

NEUTRALIZING ANTIBODIES TO HUMAN ENDOTHELIN

AMINO ACID SEQUENCES DIRECTED AGAINST IL-17A, IL-17F AND/OR IL-17A/F AND POLYPEPTIDES COMPRISING THE SAME

ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF PREVIOUSLY TREATED BREAST CANCER

Anti-TGF-beta antibodies and their use

Methods for Treating Osteogenesis Imperfecta

Monoclonal Antibodies to ELTD1 and Uses Thereof

ANTI-CSP ANTIBODY VARIANTS

Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereof

METHODS OF TREATING ALZHEIMER'S DISEASE

ATTENUATION OF BACTERIAL INFECTION

PATHOGEN BINDING METHODS AND COMPOSITIONS

Neutralizing anti-SARS-CoV-2 antibodies

Conjugates and conjugating reagents comprising a linker that includes at least two (−CH2—CH2—O—) units in a ring

IPILIMUMAB VARIANTS WITH ENHANCED SPECIFICITY FOR BINDING AT LOW PH

METHODS OF TREATING PSORIATIC ARTHRITIS USING IL-17 ANTAGONISTS

STABILIZED ARTIFICIAL IMMUNE COMPLEX ACTIVE IMMUNIZATION STRATEGY THAT SUPPORTS B CELL AND DENDRITIC CELL PROGRAMMING FOR CANCER IMMUNOTHERAPY

KAPPA MYELOMA ANTIGEN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

IL-15 AND IL-15RALPHA SUSHI DOMAIN BASED MODULOKINES

SYNERGISTIC TUMOR TREATMENT WITH IL-2 AND INTEGRIN-BINDING-FC FUSION PROTEIN

ENGINEERED NATURAL KILLER CELLS REDIRECTED TOWARD PURINERGIC SIGNALING, CONSTRUCTS THEREOF, AND METHODS FOR USING THE SAME

ANTI-EGFRVIII ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THEREOF

Combinations including ABX196 for the treatment of cancer

CANNABINOID COMPOSITIONS AND METHODS OF USE THEREOF FOR IMMUNE MODULATION

CD20 BINDING SINGLE DOMAIN ANTIBODIES

Antibodies that specifically bind to TL1A and methods of treating gastrointestinal disease

BINDING MOLECULES BINDING PD-L1 AND LAG-3

Combination of Anti-LAG-3 Antibodies and Anti-PD-1 Antibodies to Treat Tumors

METHODS OF ANTI-TUMOR THERAPY

LAG-3 binding members

METHODS FOR IDENTIFYING BIOMARKERS TO PREDICT TREATMENT RESPONSE

BISPECIFIC ANTIBODY

Anti-CD100 antibodies and methods for using the same

IL17A Antibodies and Antagonists for Veterinary Use

ANTIBODY HEAVY CHAIN CONSTANT DOMAINS

BISPECIFIC ANTIBODY SPECIFICALLY BOUND TO VEGF AND ANG2

ENGINEERED ANTIBODY FOR INHIBITION OF FIBROSIS

TNFRSF14 / HVEM PROTEINS AND METHODS OF USE THEREOF

Anti-IL-31RA antibody-containing formulations

THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

INHIBITION OF HISTONE METHYL TRANSFERASES TO TREAT CANCER

METHOD OF TREATING MALIGNANT RHABDOID TUMOR OF THE OVARY AND SMALL CELL CANCER OF THE OVARY OF THE HYPERCALCEMIC TYPE

Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy

ANTI-IgE ANTIBODIES

INTRACELLULAR DELIVERY OF ANTI-KRAS ANTIBODIES FORMULATED INTO NANOCAPSULES

ANTI-HER2 ANTIBODY-PYRROLOBENZODIAZEPINE DERIVATIVE CONJUGATE

Anti-CD98hc VNARs for crossing the blood brain barrier and type IV VNAR libraries

Antibodies to canine and feline oncostatin M receptor beta and uses thereof

INTEGRIN ALPHA10 AND AGGRESSIVE CANCER FORMS

ANTI PD-L1 ANTIBODY AND USE THEREOF

BTLA ANTIBODIES

Single domain antibody and derivative proteins thereof against CTLA4

METHODS AND USES OF VARIANT CD80 FUSION PROTEINS AND RELATED CONSTRUCTS

CD8 BINDING AGENTS

CLAUDIN-6 BISPECIFIC ANTIBODIES

CD19 ANTIBODIES AND METHODS OF USING THE SAME

ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF

FcgammaRIIB-Specific Antibodies and Methods of Use Thereof

Bispecific Antibodies for use in treatment of NLRC4-GOF inflammasomapathy

TREATMENT OF SKIN LESIONS AND PRURITUS IN PRURIGO NODULARIS PATIENTS

Antibodies to Pyroglutamate Amyloid-B and Uses Thereof

Compositions and methods to treat viral infection and co-morbidities

Antibodies specific for hyperphosphorylated tau and methods of use thereof

Humanized anti-C5 antibodies and uses thereof

COMBINATION THERAPIES USING ANTI-PSEUDOMONAS PSL AND PCRV BINDING MOLECULES

Antibody molecules to dengue virus and uses thereof

Methods and Compositions for Treating Melanoma

Circular RNA compositions and methods

T-cell modulatory multimeric polypeptides and methods of use thereof

Fluorochemical targeted therapies

High concentration anti-blys pharmaceutical formulations

RECOMBINANT PROTEINS WITH CD40 ACTIVATING PROPERTIES

THERAPEUTIC AGENTS FOR PANCREATIC CANCER

COMBINATION OF IAP INHIBITOR AND IMMUNE CHECKPOINT INHIBITOR

METHODS AND COMPOSITIONS FOR TREATING CHRONIC EFFECTS OF RADIATION AND CHEMICAL EXPOSURE

Method and system for protecting monarch butterflies from pesticides

NET STABILIZATION AS A THERAPY FOR SEPSIS

TREATMENT OF HEPATOCELLULAR CARCINOMA CHARACTERIZED BY HEPATITIS B VIRUS INFECTION

APPLICATION OF COMBINATION OF QUINOLINE DERIVATIVE AND IMMUNOMODULATOR IN PREPARATION OF ANTITUMOR DRUGS

COMBINATIONS OF TRANSCRIPTION INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS FOR TREATMENT OF DISEASE

IDENTIFICATION OF PATIENTS IN NEED OF PD-L1 INHIBITOR COTHERAPY

MULTIMERIC OX40 BINDING MOLECULES AND USES THEREOF

PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR PREVENTING HEREDITARY ANGIOEDEMA ATTACK

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

ANTI-HER2 BINDING MOLECULES

Method for increasing the efficacy of cancer therapy by administering an anti-FOLR1 immunoconjugate

Anti-Jagged1 antigen binding proteins

Antagonistic CD40 monoclonal antibodies and uses thereof

MONOCLONAL ANTIBODIES AGAINST HER2

BISPECIFIC ANTIBODIES AND USES THEREOF

Anti-ROR2 antibodies, antibody fragments, their immunoconjucates and uses thereof

Inhibitory Immune Receptor Inhibition Methods and Compositions

Tagged chimeric effector molecules and receptors thereof

Anti-lag-3 antibody polypeptide

IL-6 ANTIBODIES

Monoclonal anti-IL-1RAcP antibodies

IL-7 binding proteins and their use in medical therapy

METHODS FOR MODULATING INFLAMMASOME ACTIVITY AND INFLAMMATION IN THE LUNG

METHODS FOR TREATING OSTEOARTHRITIS PAIN BY ADMINISTERING A NERVE GROWTH FACTOR ANTAGONIST AND COMPOSITIONS CONTAINING THE SAME

HIV-1 gp120 CD4 binding site antibodies targeting HIV escape mutants

TOPICAL APPLICATION FOR AN ANTI-HSV ANTIBODY

TGF-B-RECEPTOR ECTODOMAIN FUSION MOLECULES AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND CANCERS

PREVENTION OR MITIGATION OF T-CELL ENGAGING AGENT-RELATED ADVERSE EFFECTS

COMBINATION THERAPY WITH AN ANTI BCMA ANTIBODY AND A GAMMA SECRETASE INHIBITOR

Afucosylated Anti-FGFR2IIIB Antibodies

COMBINED PHARMACEUTICAL COMPOSITION

CANCER IMMUNOTHERAPY USING COMBINATIONS OF CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND MONOCLONAL ANTIBODIES

THERAPEUTIC COMBINATIONS COMPRISING ANTI-FOLR1 IMMUNOCONJUGATES

Heterodimeric antibodies that bind CD3 and tumor antigens

CH3 DOMAIN VARIANT PAIR INDUCING FORMATION OF HETERODIMER OF HEAVY CHAIN CONSTANT REGION OF ANTIBODY AT HIGH EFFICIENCY, METHOD FOR PREPARING SAME, AND USE THEREOF

TREATMENT OF LYMPHATIC METASTASES

METHODS AND COMPOSITIONS FOR ANTI-CD73 ANTIBODIES AND VARIANTS

ENGINEERING OF AN ANTIBODY FOR TUMOR-SELECTIVE BINDING OF CD47

INTERLEUKIN-4 RECEPTOR ANTIBODY AND APPLICATION THEREOF

TYPE I INTERFERON-MEDIATED DISORDERS

Anti-FGFR2 antibodies and methods of use thereof

ADMINISTRATION OF AGENTS FOR THE TREATMENT OF INFLAMMATION

MULTISPECIFIC BINDING PROTEINS

Anti-B7-H4 antibodies and immunoconjugates

Anti-CD112R compositions and methods

Combination Immunotherapy For The Treatment of Cancer

Heterodimeric antibodies that bind somatostatin receptor 2

NOVEL BISPECIFIC CD3/CD20 POLYPEPTIDE COMPLEXES

ANTIBODIES SPECIFIC TO FCRN

ANTIBODY TO TIGIT AND USE THEREOF

METHODS AND COMPOSITIONS FOR TREATING ALLERGIC OCULAR DISEASES

METHODS AND COMPOSITIONS FOR TREATMENT OF LUPUS

ANTI-CD79B ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF, AND PHARMACEUTICAL USE THEREOF

CLAUDIN-6 ANTIBODIES AND DRUG CONJUGATES

COMPOSITIONS FOR TREATING OSTEOSARCOMA AND METHODS OF USE

Humanized anti-DKK2 antibody and uses thereof

Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods

LILRB1-based chimeric antigen receptor

METHODS FOR PHOTOIMMUNOTHERAPY AND RELATED BIOMARKERS

VACCINES FOR USE IN TREATING VARIOUS DISEASES AND DISORDERS

Autoimmune antibodies for use in inhibiting cancer cell growth

CANCER VACCINE COMPOSITIONS AND METHODS FOR USE THEREOF

COMPOSITIONS AND METHODS OF TREATING CANCER

Modulation of molecular markers using S-equol

METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER

BISPECIFIC ANTIBODIES FOR USE IN STEM CELL TRANSPLANTATION

Antibody against factor XIa in activated form of coagulant factor XI, preparation method therefor and use thereof

HDM2 ANTIBODY FOR USE IN TREATING CANCER

MUC16 specific chimeric antigen receptors and uses thereof

MUC16 specific chimeric antigen receptors and uses thereof

SYNTHETIC PEPTIDE, RELATIVE ARTIFICIAL ANTIGEN, RELATIVE ANTI-EHD2 ANTIBODY AND PREPARATION METHOD THEREOF AND USE THEREOF

Novel Fusion Proteins Specific for CD137 and GPC3

ANTI-TROPHOBLAST CELL SURFACE ANTIGEN 2 (TROP2) ANTIBODIES AND ANTIBODY DRUG CONJUGATES COMPRISING SAME

THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER

ANTI-TM4SF1 ANTIBODIES AND METHODS OF USING SAME

SUBCUTANEOUS DOSING OF ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES

ANTI-CD40 ANTIBODIES

Antagonistic CD40 monoclonal antibodies and uses thereof

Kit comprising contiguous nucleobases, including position 76, of RS5745994

POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING IL-13 AND OX40L

BISPECIFIC PROTEIN

CD25 Antibodies

Anti-MET antibodies and uses thereof

ROR1 ANTIBODY COMPOSITIONS AND RELATED METHODS

Antibodies Against ILT2 and Use Thereof

TSG-6 ANTIBODIES AND USES THEREFOR

Anti-MARCO antibodies and uses thereof

Endothelin receptor type a activity regulating antibody

Manufacturing methods for producing anti-TNF antibody compositions

Methods for Treating TNFa-Related Diseases

Methods and compositions for treating virus-associated inflammation

ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF

METHOD TO PRODUCE A HIGHLY CONCENTRATED IMMUNOGLOBULIN PREPARATION FOR SUBCUTANEOUS USE

MEANS FOR SPECIFICALLY ELIMINATING PERILIPIN-1 FRAGMENT PRESENTING ADIPOCYTES

COMPOSITIONS AND METHODS FOR USING BISPECIFIC ANTIBODIES TO BIND COMPLEMENT AND A TARGET ANTIGEN

Systems and Methods for the Production of Human Polyclonal Antibodies

LILRB1-based chimeric antigen receptor

Compositions for making and using anti-Myostatin antibodies

METHODS AND COMPOSITIONS FOR TREATING CANCER AND INFECTIOUS DISEASES

VACCINE AGAINST ACINETOBACTER BAUMANNII BASED ON CELLULAR COMPONENTS DEFICIENT IN LIPOPOLYSACCHARIDE

Anti-IGFBP-3R antibodies and methods of treating an IGFBP-3R expressing cancer